Dan Mader

To secure government funding in support of a aluminum can manufacturing facility in Ontario.

Communicating with government officials to discuss Gap Inc.'s new investments and job creation in Canada, improving end-to-end supply chain matters, effective consumer protection as it relates to privacy, combatting retail crime, and community events and partnerships.

Pursuing contracts to be awarded for the construction of housing Work with the government to expand manufacturing capabilities for factory built homes. Communication with the government to ensure effective housing supply through various policies and programs, including support for large-scale manufacturing.

Discuss the application of the Safety Data Sheet and related measures of the Hazardous Products Act and Hazardous Products Regulations to Birla Carbon’s Canadian manufacturing operations.

To seek funding support through various programs for capital investments associated with the expansion of Central Wire Industries Ltd’s manufacturing operations.

Communicating with government officials about New Haven Learning Centre's proposal to expand its facility, construct supportive housing, and enhance service offerings to support more young people and adults living with autism spectrum disorder (ASD). Communicating with government officials about potential funding opportunities to support New Haven's expansion plans and/or general operations.

To discuss Bill S-211 (National Framework on Sports Betting Advertising Act) and the importance of ensuring that sports betting advertising is regulated appropriately.

Discuss the implementation of the Clean Fuel Regulations and any potential changes to them and related climate policies for reducing emissions from the production and use of fuels including electric vehicle mandates.

Working with the government on an open and inclusive regulatory regime for generic pharmaceuticals that continues to allow the industry to grow in Canada, and discuss with the government how Apotex can work with them to ensure the security and increase the self-sufficiency of Canada’s drug supply, how the government can help ensure access to international markets including by ensuring that company employees based abroad can travel to Canada, and how the government can utilize generic and biosimilar medications to make pharmacare and other drug programs more sustainable.